WHO Says New Ebola Vaccine “Highly Effective;” Begins Extending Treatments

By , Category : Health News

Disclaimer: Results are not guaranteed*** and may vary from person to person***.

Vitamin C and the Ebola Virus“[A]n extremely promising development,” is how the director general of the World Health Organization (WHO) has described the newly developed Ebola vaccine that current trials in Guinea show to be 100% effective against the disease. The organization is so confident in the results that it has stopped randomization in the trial so that all at-risk people can become vaccinated. Prior to this decision, only those who were within close contact with a known Ebola patient were given the vaccine if they volunteered to be part of the trial.

Immense credit is being given to the Guinean government and those communities that played a role in the vaccine’s testing. The trials will continue in a more expanded form that the WHO hopes to see include as many 13- to 17-year-olds as possible and potentially children age six or higher. This will both cover more at-risk groups and allow for more definitive evidence to be gathered for the vaccine’s eventual licensing. Front-line health workers will also participate in the trial.

The vaccine, currently named “VSV-EBOV,” was developed by the Public Health Agency of Canada. The Guinea trials were implemented by the Guinean government, WHO, Doctors Without Borders, and the Norwegian Institute of Public Health with the backing and support of numerous international and national groups. Other vaccines are also being tested, but so far none are showing the same level of promise.

Since the Ebola epidemic began last year, over 10,000 people have died across Guinea, Sierra Leone, and Liberia—the three most affected countries. In Liberia alone, over 4,000 people have died from the disease. This includes a 17-year-old girl who died after Ebola was thought to have been eliminated from the country in May.

Ebola is transmitted by fluids from an infected person. Death usually results from low blood pressure due to fluid loss from intense vomiting and diarrhea, and reduced liver and kidney function. Although most well-known as a hemorrhagic fever, the bleeding from mucous membranes normally associated with Ebola is actually a less common symptom.

Source for Today’s Article:
Smith-Spark, L., “WHO: Trials Show Ebola Vaccine Is ‘highly Effective’,” CNN, July 31, 2015; http://www.cnn.com/2015/07/31/health/guinea-ebola-vaccine/index.html.




WANT MORE HEALTH NEWS & UPDATES?
Sign up for the latest health news, tips and special product offers with our daily Free e-Letters, the Doctors Health Press e-Bulletin and the Health eTalk with the Bel Marra Doctors.

Opt-in by entering your e-mail address below and clicking submit. Your e-mail will never be shared, sold or rented to anyone for promotional or advertising purposes, and you can unsubscribe easily at any time.

Yes, I’m opting in for the FREE Doctors Health Press e-Bulletin and
Health eTalk with the Bel Marra Doctors:

Adrian Newman, B.A.

About the Author, Browse Adrian's Articles

Adrian has been working in the information publishing world since 1997. But when it comes to health information, he’s a self-admitted late bloomer. A couch potato since pre-school, Adrian was raised on TV, video games and a lifestyle that led to childhood obesity that followed him well into adulthood. But when he hit his forties, he decided enough was enough. He had a family to take care of and his days of overeating, under-exercising and inactivity were going to lead... Read Full Bio »